DAVID LONARD to Cyclin-Dependent Kinase Inhibitor p21
This is a "connection" page, showing publications DAVID LONARD has written about Cyclin-Dependent Kinase Inhibitor p21.
Connection Strength
0.116
-
Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell. 2007 Jun 22; 26(6):831-42.
Score: 0.072
-
The REG? inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells. Nat Commun. 2020 08 06; 11(1):3904.
Score: 0.045